Scotts Miracle-gro CO Form 4 insider transactions
NYSE
Form 4: Scotts Miracle-Gro Director Brian E. Sandoval Reports Acquisition of Dividend Equivalent Rights
Director Brian E. Sandoval reports acquiring dividend equivalent rights convertible to 144 common shares of Scotts Miracle-Gro on March 7, 2025.
NYSE
Director Edith Aviles reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports several transactions increasing his beneficial ownership of company stock.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports several transactions involving common shares and derivative securities.
NYSE
Director Adam Hanft reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.
NYSE
Form 4: Scotts Miracle-Gro Director Mark D. Kingdon Reports Acquisition of Dividend Equivalent Rights
Director Mark D. Kingdon reports acquisition of dividend equivalent rights tied to Scotts Miracle-Gro common shares.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports transactions involving common shares and phantom stock.
NYSE
Director John R. Vines reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.
NYSE
Director Peter Shumlin reports acquiring dividend equivalent rights convertible to 157 common shares of Scotts Miracle-Gro Co. on March 7, 2025.
NYSE
Form 4: Scotts Miracle-Gro Director David C. Evans Reports Acquisition of Dividend Equivalent Rights
Director David C. Evans reports acquiring 102 dividend equivalent rights related to existing DSU or RSU grants.
NYSE
Nathan Baxter, President and COO of Scotts Miracle-Gro, reports transactions involving the company's common shares, including acquisitions at prices of $61.64, $50.74 and $63.0377.
NYSE
Director Nick Miaritis reports acquiring 31 dividend equivalent rights related to Scotts Miracle-Gro common shares on March 7, 2025.
NYSE
Form 4: Scotts Miracle-Gro Director Stephen L. Johnson Reports Acquisition of Dividend Equivalent Rights
Director Stephen L. Johnson reported acquiring 126 dividend equivalent rights related to Scotts Miracle-Gro shares on March 7, 2025.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of phantom stock convertible to common shares.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.
NYSE
Hagedorn Partnership, L.P., along with several related individuals, reported the sale of Scotts Miracle-Gro Co common shares on February 13, 2025.
NYSE
Director Brian E. Sandoval reported selling 1,513 common shares of Scotts Miracle-Gro Co. on February 12, 2025, at a weighted average price of $65.8596.
NYSE
Form 4: Scotts Miracle-Gro Executives and Hagedorn Partnership Report Changes in Beneficial Ownership
Executives and the Hagedorn Partnership reported changes in their beneficial ownership of Scotts Miracle-Gro Co. common shares following a transaction on February 7, 2025.
NYSE
4/A: Scotts Miracle-Gro Director John R. Vines Amends Form 4 Filing to Correctly Report Share Acquisition
John R. Vines, a director at Scotts Miracle-Gro, amended a previous Form 4 filing to correct the number of shares acquired on January 31, 2025.
NYSE
Brian E. Sandoval, a director at Scotts Miracle-Gro, filed an amended Form 4 to correct the number of shares acquired in recent transactions.
NYSE
Adam Hanft, a director at Scotts Miracle-Gro, amended a previous SEC filing to correct the number of shares acquired in a transaction on January 31, 2025.
NYSE
Mark D. Kingdon, a director of Scotts Miracle-Gro, filed an amendment to a previous Form 4, correcting the number of shares acquired in a transaction on January 31, 2025.
NYSE
4/A: Scotts Miracle-Gro Director Amends Filing to Correctly Report Acquisition of 3,665 Common Shares
Peter E. Shumlin, a director of Scotts Miracle-Gro, amended a previous SEC filing to correct the number of common shares acquired on January 31, 2025, reporting 3,665 shares instead of the originally stated 4,662.
NYSE
Edith Aviles, a director at Scotts Miracle-Gro, amended a previous SEC filing to correct the number of shares acquired on January 31, 2025.
NYSE
Stephen L. Johnson, a director at Scotts Miracle-Gro, filed an amended SEC Form 4/A to correct the number of shares acquired in a transaction on January 31, 2025.
NYSE
4/A: Scotts Miracle-Gro Director Nick Miaritis Corrects Stock Acquisition Details in Amended SEC Filing
Nick Miaritis, a director at Scotts Miracle-Gro, filed an amended SEC Form 4/A to correct the number of shares acquired in a recent transaction.
NYSE
Roberto Candelino, a director at Scotts Miracle-Gro, filed an amendment to a previous Form 4, correcting the number of shares acquired in a transaction on January 31, 2025.
NYSE
David C. Evans, a director at Scotts Miracle-Gro, amended a previous Form 4 filing to correct the number of shares acquired on January 31, 2025.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports a transaction involving common shares on February 4, 2025.
NYSE
Director John R. Vines reports a transaction involving Scotts Miracle-Gro Co. common shares and dividend equivalent rights.